State government links sponsors, sites and CROs in Australia

By Flora Southey

- Last updated on GMT

An online portal designed to connect sponsors with trial sites and contract research organizations has been launched by the Victorian state government in Australia.

The Victorian Clinical Trials Gateway offers a single point of entry for global companies looking to access Victoria’s universities, independent medical research institutes, clinical trial networks, biobanks and contract research organizations (CROs).

According to the government, the initiative – which responds to the growing number of trials conducted in the state – will also help local start-ups and small to medium-sized companies find support and services to attract business. 

Global companies are increasingly outsourcing their early phase clinical trials to Melbourne for three reasons: cost-efficiency, speed, and quality, said a spokesperson from the state’s department of economic development, jobs, transport and resourcing. 

“Australia offers attractive R&D tax incentives, including cash rebates,” ​she told us. 

In 2016, Outsourcing-Pharma reported​ that Australia’s tax incentive program make clinical trials up to 60% more cost-effective compared to US-based trials.  

Additionally, the state – which we were told is estimated to provide around a third of Australia’s clinical trial sites – is home to “key niche CROs” ​such as Nucleus Network, Neuroscience Trials Australia, and Cancer Trials Australia, said the spokesperson.

“Based on our expertise in treating diseases like cancer, and our large-scale infrastructure like the Victorian Comprehensive Cancer Centre, we understand that the majority of commercially sponsored cancer trials run in Australia have trial sites in Victoria,” ​she added.

According to the spokesperson, Victoria’s clinical trial process also “saves time and money by avoiding duplication and allowing flexibility without compromising quality.”

Related topics Clinical Development Phase I-II

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Content provided by Formedix | 17-Apr-2023 | White Paper

Companies often have to conduct multiple clinical trials at the same time, which means they've got to be efficient, and compliant with industry regulations....

Related suppliers

Follow us


View more